DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/9c6ng6/leukemia_drug) has announced the addition of the "Leukemia Drug Pipeline Update 2013" report to their offering.
Leukemia includes a broad variety of histological separate disorders which make the leukemia market segmented.
In addition, there are 5 suspended drugs and the accumulated number of ceased drugs over the last years amount to another 116 drugs. Leukemia Drug Pipeline Update lists all drugs and gives you a progress analysis on each one of them. Identified drugs are linked to 242 different targets. All included targets have been cross-referenced for the presence of mutations associated with human cancer.
To date 231 out of the 235 studied drug targets so far have been recorded with somatic mutations. The software application lets you narrow in on these mutations and links out to the mutational analysis for each of the drug targets for detailed information. All drugs targets are further categorized on in the software application by 61 classifications of molecular function and with pathway referrals to BioCarta, KEGG, NCI-Nature and NetPath.
Drug Pipeline Update at a Glance
Investigators
Includes more than 272 principal companies plus their collaborators. There is direct access from inside the application to web pages of all principal companies.
Indications
Included leukaemia drugs are also in development for 199 other indications, where of 104 are different cancer indications.
Targets
Mutations
All targets are cross-referenced with the Catalogue of Somatic Mutations in Cancer (COSMIC). It is designed to store and display somatic mutation information and related details and contains information relating to human cancers. To date 231 out of the 235 studied drug targets so far have been recorded with somatic mutations and the software application lets you narrow in on these mutations and links out to the mutational analysis for each of the drug targets for detailed information.
Biological Structures
The identity of available biological structures on 185 drug targets was retrieved from the RCSB Protein Databank for you to easily review the 3660 structures available today among drug targets.
For more information visit http://www.researchandmarkets.com/research/9c6ng6/leukemia_drug
About Research and Markets
Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
